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HIV-1 is still a prominent global public health issue responsible for the deaths of 
over 1 million people annually. It is a very complex virus that has been extensively 
studied over the past decade. The virus has adapted several mechanisms to maintain a 
compact genome size while also producing required essential gene products in order to 
successfully replicate itself in an efficient manner. One of the ways it has been able to 
achieve this goal is to not obey the “rules” of the central dogma of molecular biology. 
The flow of genetic information from DNA to RNA to protein, and with the outdated idea 
of one gene producing one protein, is oversimplified with our current knowledge of the 
virus. One way to maintain its strict, compact genome size requirement is to have 
inherent multiple reading frames in the same copy of its RNA. By utilizing a ribosomal 
frameshift, HIV-1 is able to produce multiple proteins without the addition of more 
genetic material. This has been extensively studied in the past, namely in the Gag-Pol 
polyprotein, which is only produced as a result of a ribosomal frameshift in the -1 
direction. We are presenting a new mechanism by which HIV-1 induces a -1 ribosomal 
frameshift. 
Nef is a protein produced by the nef gene of HIV-1 and functions to improve viral 
replication and pathogenicity. It is known to downregulate CD4 and MHC Class I 
receptors in order to evade the host’s immune cell response. Deletion of the nef gene in 
the virus has been shown to prevent long-term patients who have been diagnosed with 
HIV-1 from progressing to AIDS, indicating the importance of the Nef protein and its 
role of pathogenesis. 
There are several requirements for a ribosomal frameshift to occur. These 
requirements, containing a heptameric sequence with the format of ‘X XXY YYZ’ and a 
pseudoknot or other RNA secondary structure separated by a length of 6-12 
oligonucleotides, are all found in the nef gene. We hypothesize a -1 ribosomal frameshift 
is induced by the formation of a quadruplex (QPX). By utilizing an in vitro frameshift 
assay with a dual reporter fluorescence protein vector, where we have cloned two copies 
of nef gene fragments (one wild type and another with 3 specific bases modified to 
remove potential G QPX formation) in between a cerulean fluorescent protein and an 
orange fluorescent protein, we have found that the QPX in this region of nef is essential 
for inducing a -1 ribosomal frameshift. When three specific guanines in the nef region are 
modified into adenine bases, the ribosomal frameshifting event that occurs in the wild 
type is significantly reduced (p<0.0001), highlighting the importance between the 
formation of a QPX in the nef gene of HIV-1 and its role in inducing a frameshift in the -
1 direction during protein synthesis.
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CHAPTER I 
INTRODUCTION 
1.1 Human Immunodeficiency Virus Type 1 Origin and Impact 
Human Immunodeficiency Virus (HIV) is believed to have originated from the 
Democratic Republic of Congo dating back to 1920. It is structurally similar to Simian 
Immunodeficiency Virus (SIV), an immune deficiency disease found in monkeys and 
apes. The link between SIV and HIV stems from one particular SIV strain, called 
SIVcpz, that infects chimpanzees and is almost identical to HIV-1 in structure (1). 
SIVcpz was then transmitted to humans when chimpanzees were hunted for their meat 
and eaten (6,34). The virus is transmitted via transmission of bodily fluids, notably blood 
(34). The virus was able to spread globally by 1980, and is considered a pandemic. 
According to the Joint United Nations Programme on HIV/AIDS, it is estimated that 
36,700,000 people worldwide are currently living with HIV. Every year, there are 
1,800,000 new infections and about 1,000,000 deaths due to complications from AIDS-
related illnesses across the world. Since the start of the epidemic, there have been more 
than 35,000,000 deaths (1,2). While there have been overall recent reductions in new 
infections in the world population due to access of healthcare and increased education, 
the importance of HIV research and potential therapeutics cannot be overstated.
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1.2 HIV Virology and Structure  
HIV is a part of the lentivirus subfamily of retroviruses, that, once allowed to 
replicate, causes chronic infection to the organism and degradation of its immune system 
(3). HIV-1 targets all cells with a CD4 receptor, including CD4 T-cells, macrophages, 
dendritic cells, and monocytes, but mainly targets activated T-lymphocytes. It is spherical 
in shape and is around 120 nm in diameter, which is markedly smaller (about 60 times) 
than the cells it infects (4). It contains a double-stranded RNA genome about 9.2 kb in 
size and only 9 genes: gag, pol, env, vif, vpr, vpu, tat, rev, and nef, which are held inside a 
viral protein matrix, p24, also known as a capsid. Surrounding the capsid is a lipid 
envelope which contains several glycoproteins embedded in the membrane. Of note, 
gp120 and gp41 are named after the sizes in kDa and are ultimately responsible for 
binding, fusion, and infection of host cells (3,5). Figure 1 shows the schematic diagram of 
HIV-1.  
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Figure 1. Schematic Diagram of HIV-1 with Labeled Proteins and Enzymes. (Berthet-
Colominas, C et al. “Head-to-Tail Dimers and Interdomain Flexibility Revealed by the 
Crystal Structure of HIV-1 Capsid Protein (p24) Complexed with a Monoclonal 
Antibody Fab.” (The EMBO Journal 18.5 (1999): 1124–1136.) 
 
 
Since HIV is a retrovirus and cannot replicate on its own, it must utilize the host’s 
cellular machinery in order to produce viral proteins and proliferate more virions. The 
growth cycle is broken down into four stages: 
1. Infection 
2. DNA formation and integration 
3. Gene production 
4. Virus assembly and maturation 
Figure 2 shows the major biochemical steps that occur in the growth cycle of HIV-1. 
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Figure 2. The Major Biochemical Steps for HIV-1’s Growth Cycle. The red boxes 
indicate HIV restriction factors (TRIM5α, APOBEC3G, and SAMHD1). The green boxes 
represent antiretroviral drug treatments and what stage they target. The green boxes 
represent antagonist protein targets (Vpu, Vif, Vpx). (Barré-Sinoussi, Françoise, et al. 
"Past, Present and Future: 30 Years of HIV Research." Nature Reviews Microbiology, 
vol. 11, no. 12, Dec. 2013, pp. 877-883.) 
 
 
A typical life cycle for HIV begins with binding of gp120 to the cell’s CD4 and 
coreceptors, either CCR5 or CXCR4, which fuses the virus to the cell and allows the 
entry of the viral genetic material once the capsid is degraded. Once inside, reverse 
transcriptase (RT) converts viral RNA into its complementary DNA, while integrase 
incorporates this new viral DNA once inside the nucleus into the host’s genome. The 
DNA is then transcribed normally and produces the mRNA copy, which is then translated 
into viral polyproteins. Once these proteins are assembled, the virus is able to bud out of 
the cell. During maturation, proteases cleave the polyproteins and fully functional, 
infectious viruses are able to continue the cycle (10). Once infected, cells contain 
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400,000-2,500,000 virions (3). The HIV replication cycle happens relatively fast, in about 
2.6 days on average, and is characterized by a high mutation rate, because the viral 
polymerase (reverse transcriptase) is not subject to cellular checkpoints and DNA repair 
mechanisms. These errors are usually present during the reverse transcription and RNA 
polymerase II stages of the cycle (14,15).  Most CD4 T-cells that are infected die 
eventually due to severe cytotoxicity; however, resting T-cells can act as a reservoir for 
dormant HIV, resulting in latent infection that allows the virus to remain undetected for 
about 44 months, even if an infected person is undergoing anti-retroviral therapy (12,13). 
Taken together, both the high rates of mutation and virus latency help the virus avoid the 
host’s immune system and develop resistance to anti-retroviral drugs.  
1.3 HIV Genome and Gene Products 
HIV-1 contains a guanosine triphosphate cap on its 5’ end, a sequence of 
repeating adenosine bases known as a poly-A tail on its 3’ end, and nine open reading 
frames (ORF) that vary in size and sometimes overlap (7). These function as a way to 
assist in binding of the sequence to ribosomes in a cell, stabilize the nucleic acid and 
prevent it from enzymatic degradation once inside a cell, and allow a smaller, more 
compact genome size with improved efficiency, respectively. HIV produces 15 different 
protein products from its nine genes. The three genes gag, pol, and env, are found in all 
retroviruses and are responsible for essential polyproteins that are required for virion 
formation and propagation. Gag, (group-specific antigen) codes for proteins that make up 
the viral matrix (MA or p17), capsid (CA, or p24), nucleocapsid (NC or p9), and p6, 
which is required to separate the virion from the cell membrane (15,16). Pol 
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(polymerase) codes for the three major enzymes required to produce viral DNA and 
subsequent proteins, protease, reverse transcriptase, and integrase. Env synthesizes gp160 
and, upon glycosylation and cleavage, produces two subunits: gp120 and gp41 which 
were previously described (1,7,8,9). Two remaining genes, tat and rev produce essential 
regulatory proteins that aid in viral propagation. Tat (trans-activator of transcription) 
binds to an RNA stem loop structure which recruits other transcription factors in order to 
enhance viral transcription (17). Rev (regulator of virion proteins) localizes near the 
nucleus of the cell in order to export the incompletely spliced gag, pol, and env gene 
products out of the nucleus and allow them to be translated. The final four remaining 
genes, vpr (viral protein R), vpu (viral protein U), vif (virion infectivity factor), and nef 
(negative factor) are involved in the infectivity and pathogenicity of the virus. 
Interestingly, in HIV-1, gag and pol are in separate reading frames (pol is in a -1 
reading frame compared to gag), with the 3’ end of gag overlapping with the 5’ end of 
pol by around 200 bases as seen in Figure 3. Furthermore, Pol proteins are only produced 
as a fusion protein Gag-Pol, despite pol having no start codon in its RNA sequence. The 
gag-pol frameshifting sequence has been studied extensively by Varnam et al. in 1988 
(18). They determined the Gag-Pol fusion proteins are synthesized when the ribosome 
has a frameshift in the -1 sequence relative to gag, and only occurs around 5-10% of the 
time. This process is under translational control. The N-terminus of the pol gene encodes 
the protease that cleaves itself from the Gag-Pol protein, the reverse transcriptase 
enzyme, and the integrase as previously described. Figure 3 depicts HIV-1’s genome and 
the relative positions of its genes, as well as the various frameshifts and overlaps in genes 
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(19). The tat and rev genes also have two coding exons each that are separated on either 
side of and overlapping the env gene. 
 
 
Figure 3. The Genome of HIV-1. The open reading frames (ORF) are shown in rectangles 
with the location of the genes’ starting positions shown by the number in the top left 
corner. Korber et al., Numbering Positions in HIV Relative to HXB2CG, in the database 
compendium, Human Retroviruses and AIDS, 1998. 
 
 
1.4 Genetic Code Expanded Through Reading Frames 
The classic theory in molecular biology, which describes the flow of genetic 
information from DNA to RNA to protein, has since been outdated. While this is 
generally understood as a universal theme among living organisms, that DNA is 
transcribed into RNA, which is then read by ribosomes in codons of 3 bases long, it fails 
to describe the flow of genetic information of retroviruses. The previous description “one 
gene, one protein”, with the advancement of molecular biology and genetics, is no longer 
true and is an oversimplification. As previously described, there are multiple 
contradictions between the central dogma and HIV-1. First, HIV-1’s genome codes for 
reverse transcriptase, which goes the opposite direction of the classic theory; it takes viral 
RNA and generates complementary double stranded DNA, which the host cell will then 
transcribe back into RNA, and later makes proteins. This adds a layer of complexity to 
how the flow of information exists in modern biology. Secondly, as shown in Figure 3, 
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several of the coding exons in HIV-1’s genome overlap and do not function normally as a 
eukaryotic organism’s genome would. While the central dogma may not apply 
completely to all cellular processes, retroviruses have been able to take advantage of the 
“rules” of biology and become successful parasites. 
 The 9.2 kb size of HIV-1’s genome (7), in comparison to a human’s 3 billion kb, 
is drastically smaller. As a result, retroviruses have evolved mechanisms in order to 
maximize the efficiency of their genome while maintaining its small size. One way to 
achieve a feature of alternative RNA splicing that is akin to the eukaryotic genome is by 
utilizing ribosomal frameshifting and in some cases, termination suppression. In addition 
to the Gag-Pol fusion protein formed from the gag-pol genes, ribosomal frameshifting in 
the -1 reading frame has also been seen in the env gene via a “hungry codon” 
phenomenon (20, 29). The readthrough of a UGA stop codon has been shown in the nef 
gene via “anti-sense” tethering between viral mRNA and host selenoproteins (21). These 
phenomena can allow the production of multiple isoforms of protein from the same 
sequence of RNA. In nature, these processes occur at a low frequency which suggests the 
proteins that are formed as a result of frameshifting or readthrough of a stop codon are 
not critical to survival of the virion, but instead modulate pathogenicity, virion 
infectivity, and signal transduction pathways.  
Codons are read in triplet from an mRNA strand in order to produce amino acid 
polymers and form proteins. Protein synthesis starts with the AUG codon and ends with 
one of three stop codons, UGA, UAA, and UAG. Codons are degenerate, meaning 
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multiple codons, when read by the ribosome, will produce the same amino acid. For 
example, the amino acid alanine is produced by the mRNA sequences GCU, GCC, GCA, 
and GCG. The third position in the codon, also known as the wobble position, is 
degenerate and less important to determining which amino acid will be added to the chain 
(23). Regardless of what the third nucleic acid in the codon is, if the first two are both 
read as “GC”, alanine will be added to the growing polymer by the tRNA molecule 
during protein synthesis. There are three reading frames for a 5’ to 3’ sequence of 
mRNA: zero, which is the standard reading frame, +1, and -1. Ribosomal frameshifting 
occurs when the ribosome is displaced one nucleic acid in the +1 or -1 direction. In 
nature, the frequency of a frameshift occurring is low but not uncommon and is not 
limited to only viruses (24).  
1.5 HIV-1’s nef Gene Exhibits Ribosomal Frameshifting  
 Nef is a small, 27 kDa, myristoylated protein produced in the early stage of the 
HIV-1 life cycle and is known to be fundamental to viral pathogenicity and replication. 
Once it is produced, it is localized to the cell membrane. It downregulates both CD4 
receptors and MHC class 1 molecules that are found on the surface of cells that signal an 
immune response. Nef internalizes CD4 receptors and redirects them into the cell’s 
lysosomes, suggesting that Nef interacts with intracellular trafficking pathways (22). It 
has been shown that deletion of the nef gene in humans with long-term nonprogressive 
HIV-1 halts the progression of AIDS, which indicates its role in disease progression (23). 
The nef gene exhibits a potential overlapping region with an “ideal” XXXYYZ pattern -1 
frameshifting signal upstream from a G-quadruplex (QPX), which we suspect induces 
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and regulates frameshifting. QPXs have been studied extensively in eukaryotes, but only 
to a lesser extent have they been studied in viruses. Several quadruplex-stabilizing drugs 
have been found and documented, notably TMPYP4, berberine, and Reservatrol. 
Monovalent cations, in particular, Na+ and K+ ions, have been shown to help stabilize 
quadruplexes as well. The scope of this project is to better understand what happens 
during a ribosomal frameshift, as well as the function the G-quadruplex has in nef. If we 
are able to understand the function of a QPX and its role on nef, we could potentially use 
them as a target for pharmaceutical agents, possibly affecting its pathogenicity or reduce 
its virulence. 
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CHAPTER II 
G-QUADRUPLEX AND PSEUDOKNOT FUNCTION IN THE HIV-1 NEF  
 CODING REGION AS A FUNCTION OF CO-TRANSLATIONAL GENETIC 
SWITCHING DURING PROTEIN SYNTHESIS 
 
2.1 Abstract  
Quadruplexes (QPX) are formed as a result of repeating guanine bases in nucleic 
acids that form tetrads. These G-tetrads are stabilized by Hoogsteen hydrogen bonding, a 
unique variant of Watson-Crick base pairing. QPX also feature a monovalent cation 
positioned in the middle of the tetrad for additional electrostatic stability. In the coding 
region of the nef gene of HIV-1, there is an ideal heptameric “slippery” sequence, 
UUUAAAA, that is 7 base pairs upstream from a QPX. This region has been shown to 
feature a -1 ribosomal frameshift. Because this region is in the highly stable polypurine 
tract, a highly conserved region in all variants of HIV-1, we suspect this region is 
responsible for formation of a QPX and its role in inducing a ribosomal frameshift in the 
-1 direction. Using an in vitro frameshift assay and a dual-reporter fluorescent protein 
vector, in which cloned presumed nef gene fragments have been added in between two 
fluorescent proteins, we have shown that the -1 ribosomal frameshift is dependent upon a 
QPX being formed.
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2.2 Introduction  
G-quadruplexes (QPX) are nucleic acid structures that form in guanine-rich 
sequences of both DNA and RNA. Repeating G bases fold over and stack on top of one 
another, forming inter- or intramolecular four-stranded structures, known as a G-tetrad. 
They are stabilized by Hoogsteen hydrogen bonding, a unique variant of standard 
Watson-Crick base pairing, with a monovalent cation (usually Na+ or K+) located at the 
center sandwiched between the pairs of tetrads for additional stability through 
electrostatic interactions (27). QPXs can fold intramolecularly from a single strand of 
repeating G bases, or intermolecularly through dimerization or tetramerization of separate 
sequences. Depending on the orientation of the sequences, they can be designated as 
parallel, where the 5’ and 3’ ends line up together, antiparallel, where one strand is 5’ to 
3’ and another strand runs opposite in the 3’ and 5’ direction, or mixed, a combination of 
the two (27). The tetrads that result from these secondary interactions are planar and can 
stack on top of one another, forming a QPX, as shown in Figure 4.
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Figure 4. Chemical Structures and Schematic Planar Representations of QPXs. A) left: a 
chemical structure of the tetrad shown of 4 guanine bases surrounding a monovalent 
cation, shown as M+. Right: the planar representation of the QPX with the red dots each 
signifying a guanine. The red dashed lines indicate Hoogsteen base pairing. B) the 
folding orientations parallel, antiparallel, or mixed. (Ruggiero, E. et al.; G-quadruplexes 
and G-quadruplex ligands: targets and tools in antiviral therapy, Nucleic Acids Research, 
Volume 46, Issue 7, 20 April 2018, Pages 3270–3283) 
 
 
QPXs have been identified in numerous genomes including mammalian, 
protozoa, yeasts, bacteria, and of course, viruses, and are a focus of nucleic acid research. 
QPXs are not randomly distributed but are generalized in areas of genomic importance, 
namely telomeres, oncogenes, gene promoters, and origins of DNA replication (25,27). 
They have also been found in other open reading frames and untranslated regions of the 
eukaryotic genome, suggesting they are involved in regulating biological pathways such 
as transcription, translation, replication, and stability of the genome. In the example of 
telomeres, QPXs have been shown to inhibit telomerase, the enzyme responsible for 
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adding bases to the end of chromosomes, which prevents extension of the sequence of 
DNA. If QPXs are able to stabilize and prevent telomerase activity in tumor cells, a new 
treatment could be proposed in treating cancer and limiting tumor growth (25). If we can 
achieve a better understanding of the mechanisms behind the formation, structure and 
stability of QPXs, we could potentially use them as drug targets for clinical applications.  
QPX formation in the nef gene of HIV-1 has been previously studied and 
documented using computational and experimental approaches (28). Richter et al. 
determined three potential QPX formation sites in the nef gene, Nef 8528, Nef 8547, and 
Nef 8624 (Figure 5). Ribosomal frameshifting in the nef gene has already been shown to 
occur (21). With this information and using the potential QPX locations as described in 
the Richter study above, we are proposing that one of the three QPX that they identified, 
Nef 8624, is essential in order for the -1 ribosomal frameshift to occur in the nef gene. If 
confirmed, we can demonstrate the co-translational genetic switching that occurs between 
multiple protein isoforms in HIV-1. Additionally, if we are able to inhibit the QPX and 
the resulting ribosomal frameshift in nef, we could prevent the formation of these protein 
isoforms, which could serve as a potential target for antiviral drugs. 
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Figure 5. The Three Putative QPX Formation Sites in the Nef Gene and Corresponding 
Sequence and Location in the Gene. In blue, Nef 8528, green, Nef 8547, and orange, Nef 
8624. (Perrone, Rosalba et al. “Formation of a Unique Cluster of G-Quadruplex 
Structures in the HIV-1 nef Coding Region: Implications for Antiviral Activity.” Ed. 
Jianming Qiu. PLoS ONE 8.8 (2013): e73121. PMC. Web. 20 June 2018.) 
 
 
As mentioned before, ribosomal frameshifting is a result of the ribosome in a cell that, 
instead of reading in the zero frame, moves forward or backward one single nucleotide. 
HIV-1 has several ORF’s that spans its entire genome as seen previously in Figure 
3.  The formation of the Gag-Pol and fusion protein exemplifies ribosomal frameshifting 
in the -1 direction, enabling it to regulate the expression of its genes while keeping its 
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genome relatively compact (29). There are three requirements for the induction of a -1 
ribosomal frameshift:  
1. A heptameric slippery sequence where the frameshifting is set to occur. For optimal 
efficiency, the sequence ‘X XXY YYZ’ is considered to be ideal due to the 
degeneracy of codons. The wobble position is the least important when determining 
the amino acid that will be produced. Because of this, when the tRNA molecule is 
ready to add an amino acid to the growing peptide and it encounters the code ‘XXY’, 
slippage could occur in the -1 reading frame and the ribosome will read that codon as 
‘XXX’. The degeneracy of the code and the wobble position allows this frameshift 
and translation of the new sequence to occur. 
2. A spacer sequence about 6-12 nucleotides long. 
3. A downstream pseudoknot or other large RNA structure such as a hairpin or stem-
loop. 
The exact mechanism of the frameshift and how it is induced by encountering a 
pseudoknot or QPX is not entirely clear. It has been shown that when the ribosome is 
translating a sequence of mRNA and encounters one these structures, it pauses over the 
heptameric slippery sequence. During the pause, the ribosome is able to slip into another 
reading frame, causing the frameshift. The downstream pseudoknot or QPX is essential 
for this process to occur in the -1 direction. However, since the sequence that makes up 
the pseudoknot or QPX also needs to be read by the ribosome and translated into protein, 
the stability and structure of the pseudoknot or QPX is also important to its function. If 
the structure is too stable, the ribosome may not be able to translate the remainder of the 
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mRNA. Quadruplexes in DNA have been shown to stall replication, transcription, and 
inhibit DNA binding protein function in cells, possibly linking its role in cell division and 
development (30). The geometry and surface charge of a QPX might also have an effect 
on the efficiency of the frameshifting rate. 
The putative Nef 8624 site described by Richter et al. happens to be located just a few 
bases downstream of an ideal heptameric slippery sequence required for a -1 frameshift, 
UUUAAAA. Downstream to this sequence, there is an RNA pseudoknot located about 7 
nucleotide bases away, which overlaps exactly with the region containing the potential 
QPX Nef 8624. This sequence is located in a highly conserved region of HIV-1’s RNA 
called the polypurine tract (PPT), an area of repeating purines. PPTs are relatively 
resistant to degradation by the ribonuclease H activity of reverse transcriptase and is also 
the site of plus-strand DNA synthesis (31). When the UUUAAAA sequence is mutated to 
UUUAAGA, (changing the codon AAA that produces lysine into AAG, coding for 
arginine), and the cell is arginine deficient, arginine acts as a ‘hungry codon’. A hungry 
codon is described when a particular amino acid, in this case arginine, is required to for 
peptide formation, but the aminoacyl tRNA is in short supply. Arginine is known to play 
a role in preventing oxidative stress, so if the cell is Arg deficient, and when the ribosome 
encounters the codon for Arg, AAA, it pauses, and a -1 frameshifting event is more likely 
to occur (20). Similarly, we are hypothesizing that when the ribosome encounters a QPX 
or pseudoknot, it pauses, resulting in a -1 frameshift. The QPX of Nef 8624 is located in 
the PPT and has a potential role in enhancing the -1 ribosomal frameshifting frequency 
by causing the ribosome to pause during translation. Because Nef 8624 was identified as 
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having the highest stability of the three possible QPX formation sites (28), we 
hypothesize that when the ribosome encounters this stable structure, it briefly pauses due 
to a physical obstruction, enhancing the -1 ribosomal frameshift. 
 
 
Figure 6. Top: The mRNA Sequence in HIV-1’s Nef Gene that can Assume the 
Quadruplex. Bottom left: Quadruplex form. Bottom right: Psuedoknot form. These 
structures show the alternate molecular conformations of the viral RNA. In this study, we 
hope to directly link the QPX that is believed to form in Nef 8624 and its role in inducing 
a -1 ribosomal frameshift. If we alter the nef gene and eliminate the suspected QPX 
formation, frameshifting will not occur, implicating its role in the process.  
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2.3 Materials and Methods 
The first step was to create two expression vectors containing the putative HIV-1 
nef frameshift site previously predicted by Taylor and coworkers (21), in one of which is 
cloned the wild-type putative QPX-forming nef gene fragment; the second vector 
contains a mutated, QPX-inhibited nef gene fragment. In both constructs, the wild-type or 
mutated nef frameshift sequences are inserted between two fluorescent protein reporter 
genes, in order to assess the frameshift efficiency in vitro. The QPX-inhibited nef gene 
fragment was created to mutate specific guanine bases into adenine bases, effectively 
disabling the possibility of forming a QPX. Three specific guanines were mutated into 
adenines in order to remove the potential for QPX formation. This maintains the slippery 
sequence that is critical to enable the -1 frameshift, as well as the predicted RNA hairpin 
loop, and only changes one amino acid (glycine to glutamine) in the transframe fusion 
protein sequence, which should not affect protein yield significantly. These three guanine 
bases were selected because their absence (via mutation to adenines) would have the 
highest probability of disabling formation of the QPX, considering the work on the 
putative QPX formation study done by Richter et al. (28). The construct was designed to 
have an upstream crulean fluorescent protein (CFP) reporter gene and a downstream 
orange fluorescent protein (OFP) reporter gene that is in the -1 reading frame. When 
allowed to grow, all the transfected cells will produce CFP. However, because the OFP is 
in the -1 reading frame, orange fluorescence will only occur when a frameshift happens. 
Fluorescence was measured using an EVOS fluorescence microscope and quantified 
using ImageJ NIH software. If our hypothesis is correct, the frameshift frequency of the 
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mutated, QPX-inhibited nef gene fragment is expected to be significantly less than the 
wild type nef gene fragment. 
2.3.1 Plasmid Construct  
To construct our plasmids, we used the mCerulean C1 (4731 bp) expression 
vector which contains the enhanced cerulean fluorescent protein (ECFP) gene (722 bp) 
upstream of the multi cloning site (added by AddGene.org). The nef gene has an inherent 
BglII (A’GATCT) restriction site upstream of the frameshift site, which allows the 
ligation of the nef gene inserts via another BglII restriction site in mCerulean C1, which 
was digested using the BglII restriction enzyme at the multicloning site. ECFP is the 
reporter gene upstream from the inserted nef frameshift sequence in the constructs. We 
are using pmOrange N1 mammalian vector (obtained from Clontech lab. Inc.) as a source 
for the orange fluorescent protein gene with multicloning sites added, which is located 
between a BamHI (G’GATCC) restriction site and a downstream multicloning site. ECFP 
was first ligated with the nef inserts via the BglII site, which produced ECFP attached 
with the wild type (WT) nef and mutated (mut) nef gene fragments. A second ligation 
occurred between the attached ECFP-nef into the mOrange vector, using a BamHI 
restriction site. The closed, completed construct was achieved using NheI sites to ligate 
both mCerulean and pmOrange. 
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2.3.2 Plasmid nef Inserts 
Nef-fs Wild type (nef-fs WT):  
ctg tag atc tta gcc act ttt taa aag aaa agg ggg gac tgg aag ggc taa ttc act ccc aaag 
Nef-fs WT mutated to create 3’ BamH1 site: 
ctg tag atc tta gcc act ttt taa aag aaa agg ggg gac tgg aag ggc taa ttc gga tcc aaag 
Nef-fs mutant to disrupt quadruplex formation (nef-fs mut): 
ctg tag atc tta gcc act ttt taa aag aaa aga agg gac tgg aag agc taa ttc gga tcc aaag 
The bases in blue indicate the BglII site, while the bases in red indicate the 
BamHI site that was added to the end of the nef gene. The bases in teal indicate the 
specific guanine bases that were mutated into adenine. The sequences in the middle 
indicate the -1 frameshifting site and location of the proposed QPX formation. The nef-fs 
WT and nef-fs mut were designed and ordered from IDT Inc. The inserts were mutated to 
create a BamHI site at the 3’ end in order to ligate with pmOrange. Nef originally has a 
BglII restriction site upstream from the QPX-forming region. 
2.3.3 In Vitro Frameshifting Assay 
The construct was transformed into JM109 competent cells and grown on 
lysogeny broth (LB) plates containing kanamycin. The clones were harvested, amplified, 
and purified using a DNA purification kit. The plasmids were sent to Eurofins Genomics 
to be sequenced to confirm the formation of the construct.  HEK-293 mammalian cells 
were incubated at 37° C and 5% CO2 atmosphere on a black clear-bottom 96 well plate 
seeded with 0.5x10^5 cells per well. After growing to confluency, the cells were 
transfected with the plasmid constructs, Lipofectamine 2000 (Invitrogen), OptiMEM I, 
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and 10% FBS-enriched DMEM for 12 hours, after which the media was replaced with 
100 µl of the enriched DMEM and allowed to grow for 4 days. The expressed 
fluorescence protein levels were then observed using an EVOS fluorescence microscope. 
The parent plasmids mCerulean and pmOrange were used as positive controls, while 
untransfected cells were used as a negative control. Fluorescence images were taken at 10 
different well locations for each variable treatment. The intensity in relative light 
intensity units was measured using NIH ImageJ software (35). Statistical analysis was 
done using Graphpad software. 
2.4 Results and Discussion  
CFP and OFP intensities of both nef-fs WT and nef-fs mut were measured and 
compared to the controls as listed above. The upstream CFP was expressed in both nef-fs 
WT (3780±498) (SEM) and nef-fs mut (5675±962) (SEM) constructs, with only a minor 
decrease in nef-fs WT as compared to nef-fs mut. This relative frameshifting difference is 
not statistically significant and this is within experimental error (p=0.0998). However, 
there is a highly significant (p<0.0001) decrease in OFP expression shown in nef-fs mut 
(211 ± 200) (SEM) as compared to nef-fs WT (1983 ± 255) (SEM). This indicates the 
nef-fs WT construct undergoes frameshifting in the -1 direction and expresses OFP, 
while nef-fs mut, with its mutated DNA sequence that inhibits the putative quadruplex 
from forming, does not. As expected, the untransfected cells produced no fluorescence 
and, compared to nef-fs mut OFP production, there is no significant difference (p=0.31). 
In the nef-fs WT construct, there is a highly significant (p<0.0001) amount of 
frameshifting occurring (OFP 1983 ± 255) (SEM) as compared to the untransfected cells 
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(OFP 0 ± 0). These results are consistent with our hypothesis that the previously 
identified quadruplex in the nef gene of HIV-1, that by serving as the RNA structural 
element in the bipartite frameshift signal (along with the required slippery sequence), 
plays an essential role in inducing a -1 ribosomal frameshift in this important viral gene. 
This is a functional role of a QPX that has not been reported previously. 
 
 
Figure 7. CFP and OFP Expression Levels in Nef-fs mut and Nef-fs WT Constructs. 
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Figure 8. CFP and OFP Expression Levels in the Tested Variables. From left: nef-fs mut, 
nef-fs WT, parent CFP, parent OFP, and untransfected cells. 
 
 
2.5 Future Work and Research  
A 0% frameshift efficiency with modified stop codons could be added as an 
additional negative control and the difference between the nef-fs mut, QPX-inhibited 
construct could be compared. QPX-stabilizing drugs such as TMPYP4 could be added to 
both nef-fs WT and nef-fs mut in order to further showcase the decreased efficiency of 
frameshifting that occurs when a QPX is unable to form, as TMPYP4 is expected to have 
no effect on the nef-fs mutant construct. Further future work could be done using a 
different neuroblastoma cell line. Previously, when neuroblastoma cells were introduced 
to aconitine, a sodium channel opening drug, a decrease in stability of the QPX found in 
the ChAT gene was observed (32). An assay involving various monovalent cations in 
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different concentrations using this cell line could help determine the role of Na+, K+, and 
Li+ in quadruplex stability. 
26 
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